Michael S Leapman

17PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)MortalityMedical biotechnology diagnostics (incl. biosensors)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 03, 2026
Adoption and Regional Variation of Prostate-Specific Membrane Antigen Positron Emission Tomography in the United States.

Michael S Leapman, Jessica B Long, Sarah Westvold

|Nov 03, 2025
Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer.

Aaron P Mitchell, Andrew Salner, Paul Palyca

|Sep 22, 2025
Opioid prescribing trends and pain scores among adult patients with cancer in a large health system.

Laura Van Metre Baum, Pamela R Soulos, Madhav Kc

|Nov 04, 2024
County-level racial disparities in prostate cancer-specific mortality from 2005 to 2020.

Samuel L Washington Iii, Mary Fakunle, Lufan Wang

|Oct 28, 2024
Diagnostic utility of prostate health index density prior to MRI-ultrasound fusion targeted biopsy.

Benjamin H Press, Soum D Lokeshwar, Lindsey Webb

|Jun 19, 2024
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy.

Gabriela M Diaz, Lindsey T Webb, Maximilian J Rabil

Pageof 3